Impact of 4PCP on Practitioner and Patient Outcomes
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Oct 11, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program called 4PCP, which aims to help patients with chronic pain while also reducing the need for opioid medications. The goal is to see if this program can improve health outcomes for both patients and healthcare providers. The study will provide the 4PCP training at no cost to doctors who participate, making it easier for them to learn new ways to help their patients manage pain effectively. If the program proves to be successful, it could lead to better support from health insurers and healthcare facilities in the future.
To join the study, healthcare providers need to be general practitioners who work with patients experiencing chronic pain and can communicate in English. Patients who may qualify need to be between the ages of 14 and 80, have been living with chronic pain for at least three months, and speak English. They should also have visited their doctor at least twice before enrolling in the trial. Participants will complete questionnaires and attend training sessions, and their feedback will help researchers determine how well the program works. Overall, this trial could lead to promising new approaches for managing chronic pain in a more sustainable way.
Gender
ALL
Eligibility criteria
- Practitioner Inclusion:
- • General practitioners
- • Part of a practice that has their own identifiable patient population including patients with chronic pain
- • Able to fully answer questionnaires
- • Able to attend 4PCP course
- • English speaking
- Patient inclusion:
- • Age 14-80
- • Self-report of chronic non-malignant pain \> 3 months
- • No foreseeable or planned surgeries for chronic pain
- • Has attended at least 2 established visits in the enrolled practitioner's practice
- • English speaking
- Practitioner exclusion:
- • Pain specialists
- • Unable to fully answer questionnaires
- • Unable to attend the 4PCP course
- • Non-English speaking
- Patient exclusion:
- • Unable to answer questionnaires (e.g. stroke, dementia, developmental delay, etc.)
- • Followed in a specialty pain clinic (PCP not managing pain care)
- • Sickle cell disease
- • Prisoners
- • Non-English speaking
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Milwaukee, Wisconsin, United States
Richmond, Virginia, United States
Madison, Wisconsin, United States
Madison, Wisconsin, United States
Patients applied
Trial Officials
Thomas Chelimsky, M.D.
Principal Investigator
VCU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials